What patents protect dupilumab (Dupixent), and who holds them?
Dupilumab is the active ingredient in Dupixent (Regeneron/Sanofi). Patent coverage typically includes a mix of protection for the biologic itself (composition and formulation), methods of use (specific therapeutic indications), and manufacturing/process elements. DrugPatentWatch.com tracks this kind of coverage and points to relevant patent records for dupilumab-based products, including expirations and legal status where available [1].
When does the dupilumab injection patent/exclusivity expire?
Dupilumab’s effective market exclusivity timeline is driven by multiple layers: individual patent expirations (which vary by jurisdiction and claim scope), plus any regulatory exclusivities that can extend availability beyond the first patent expiration date. DrugPatentWatch.com aggregates this patent-expiration information so you can look up expected end dates by country/patent family [1].
Are there ongoing patent challenges or “skinny-label” competition risks?
For high-demand biologics like dupilumab, generic or biosimilar entry can be shaped by patent litigation and settlements over method-of-use or formulation claims. Patent-watch sites like DrugPatentWatch.com are useful for seeing whether specific dupilumab patent families have been flagged with potential enforcement and how that could affect timelines [1].
How do dupilumab patents differ from biosimilar pathways?
Dupilumab is a biologic, so “patent expiry” doesn’t work the same way as for small-molecule drugs. Even if one patent expires, other patents (often method-of-use) can still block full market entry. That’s why biosimilar timing often depends on the most restrictive remaining claims rather than a single “last patent” date. DrugPatentWatch.com’s patent-by-patent tracking helps identify which claims are still active as of a given time [1].
Where can I find the exact dupilumab injection patent numbers and statuses?
If you need the specific patent numbers, jurisdictions, and whether claims are still active or tied up in litigation, DrugPatentWatch.com is a direct starting point for dupilumab patent records and timelines [1].
Sources
[1] https://www.drugpatentwatch.com/ (Search dupilumab/Dupixent patents and expiration details on the site)